Synonyms: example 1 [WO2016094821A2]
rezivertinib is an approved drug
Compound class:
Synthetic organic
Comment: The chemical structure submitted to the WHO for INN rezivertinib, is identical to the structure of example 1 that is claimed in patent WO2016094821A2 by Beta Pharma [1]. This patent claims novel EGFR inhibitors that are active against mutated EGFRs that are found in cancers, i.e. third generation EGFR inhibitors. From Beta Pharma's declared pipeline, example 1 is likely to be BPI-7711, which is being investigated for the treatment of EGFRT790M-mutant non-small cell lung cancer. We await formal name>structure confirmation. Experimental evidence in WO2016094821A2 indicates that example 1 is orally bioavailable.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. China NMPA (2024) |
International Nonproprietary Names ![]() |
|
INN number | INN |
11229 | rezivertinib |
Synonyms ![]() |
example 1 [WO2016094821A2] |
Database Links ![]() |
|
GtoPdb PubChem SID | 404859075 |
PubChem CID | 118912975 |
Search Google for chemical match using the InChIKey | BPMZUKYFIDPLEA-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | BPMZUKYFIDPLEA |
Search PubMed clinical trials | rezivertinib |
Search PubMed titles | rezivertinib |
Search PubMed titles/abstracts | rezivertinib |
UniChem Compound Search for chemical match using the InChIKey | BPMZUKYFIDPLEA-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BPMZUKYFIDPLEA-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Rezivertinib (links to external site)
Cat. No. HY-109189 |